ZoomInfo Technologies Inc. (GTM) vs HIVE Digital Technologies Ltd. (HIVE)

GTM leads on 8 of 10 compared metrics.

A side-by-side comparison of ZoomInfo Technologies Inc. and HIVE Digital Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total returnGTM vs HIVE

growth of $100 · dividends reinvested · last 6y
GTM -91.4%HIVE +97.3%HIVE compounded faster
Log scale — wide-divergence pair
1101001k10kStart $100202120222023202420252026$9$197
GTM HIVE

GTM vs HIVE: by the numbers

  • GTM is the larger company ($861M vs $792M market cap).
  • GTM is profitable (10.10% net margin) while HIVE runs a net loss (-49.85%).
  • HIVE grew revenue faster over the past five years (34.49% vs 18.92% CAGR).

Which is better, GTM or HIVE?

Metric tally: GTM 8 · HIVE 2

It depends on what you're optimizing for:

GrowthHIVE(faster 5Y revenue CAGR)
QualityGTM(higher ROIC)

Metrics side by side

Valuation

MetricGTMHIVE
P/E ratio7.44
Forward P/E2.64
P/S ratio0.742.24
P/B ratio0.631.26
PEG ratio0.07
EV / EBITDA7.2214.12
FCF yield40.49%

Profitability

MetricGTMHIVE
Gross margin84.21%-21.00%
Operating margin19.40%-40.22%
Net margin10.10%-49.85%
ROE8.60%-28.04%
ROIC2.48%-19.94%

Growth (annualized)

MetricGTMHIVE
Revenue CAGR (5Y)18.92%34.49%
FCF CAGR (5Y)11.57%
Total return CAGR (5Y)-44.16%-22.94%

Frequently asked

Which is better, GTM or HIVE?
It depends on your goal. growth: HIVE (faster 5Y revenue CAGR); quality: GTM (higher ROIC). Across all compared metrics, GTM leads 8 to 2.
Which has grown faster, GTM or HIVE?
Over the past five years, HIVE grew revenue faster — GTM at a 18.92% CAGR versus HIVE at 34.49%.
Is GTM or HIVE more profitable?
GTM runs the higher net margin — GTM at 10.10% versus HIVE at -49.85%.
Which has been the better investment, GTM or HIVE?
Over the past 5-year, HIVE delivered the higher annualized total return — GTM at -44.16% versus HIVE at 40.30%. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 25, 2026.